Has Kevin Mott, MD received payments from drug or device companies?

Yes. Drug and device makers reported $33,078 in general payments to Kevin Mott, MD across 716 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kevin Mott, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kevin Mott, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kevin Mott, MD

MOHS-Micrographic Surgery · Loveland, CONPI 1295776201

Payments from drug & device makers

$33,078in general payments, 2019–2025

Across 716 payments — averaging $46.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$22K
Novartis$1K
Regeneron Healthcare Solutions, Inc.$1K
Sun Pharmaceutical Industries Inc.$979
Sanofi$859
Johnson & Johnson$639
plus $6K from 37 others

What the payments were for

Food & beverage$13,15640%
Education$1941%
Gifts$19,72860%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	141	$22,259
Novartis	82	$1,232
Regeneron Healthcare Solutions, Inc.	41	$1,004
Sun Pharmaceutical Industries Inc.	53	$979
Sanofi	41	$859
Johnson & Johnson	30	$639
LEO Pharma Inc.	28	$637
Lilly USA, LLC	36	$622
UCB, Inc.	30	$597
Pfizer	38	$580
Amgen	30	$564
E.r. Squibb & Sons, L.L.C.	25	$391
Helsinn Therapeutics (U.S.), Inc.	12	$311
Incyte Corporation	23	$278
Ortho Dermatologics, A Division Of Bausch Health US, LLC	13	$257
Galderma Laboratories, L.p.	14	$246
Boehringer Ingelheim	10	$195
Arcutis Biotherapeutics, Inc.	11	$184
Organogenesis Inc.	6	$175
Almirall LLC	8	$161
Genentech USA, Inc.	6	$97
Kyowa Kirin, Inc.	4	$83
VYNE Pharmaceuticals Inc.	3	$65
Janssen Scientific Affairs, LLC	1	$65
Revance Therapeutics, Inc.	2	$65
Biofrontera Inc.	3	$62
Mimedx Group, Inc.	2	$61
Convatec Inc.	2	$56
Organon	3	$47
DUSA Pharmaceuticals, Inc.	3	$43
Dermavant Sciences, Inc.	2	$33
Bristol Myers Squibb	2	$25
Solta Medical, A Division Of Bausch Health US, LLC	1	$24
Biocon Biologics Inc	1	$24
Dermira, Inc.	1	$20
Kerecis Limited	1	$20
Integra Lifesciences Corporation	1	$20
EPI Health, LLC	1	$19
Mayne Pharma Commercial LLC	1	$19
Acera Surgical, Inc.	1	$19
Dilon Technologies, Inc.	1	$17
Verrica Pharmaceuticals Inc.	1	$14
Sensus Healthcare, Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,078 in reported general payments places this provider in the 85th percentile of 37 mohs-micrographic surgery providers in Colorado.

See all mohs-micrographic surgery providers in Colorado →

Medicare billing

Part B allowed, 2024

$827,353

Medicare patients

672

Services billed

2,799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	21	$94
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	17	$87

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Loveland

Bruce KornfeldLoveland$1K
David ClarkLoveland$15
Joel CohenGreenwood Village$2M
Maryam AsgariAurora$780K
Matthew MahlbergCentennial$219K
Shawn AllenBoulder$69K
Karen NernEdwards$28K
Vinh ChungColorado Springs$10K
Brett MathesonColorado Spgs$10K
Lauren BonatiEdwards$8K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →